The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Fernand Labrie

Oncology and Molecular Endocrinology Research Center

Laval University Hospital Research Center (CRCHUL) and Laval University

Quebec

Canada

[email]@*.ulaval.ca

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Oncology and Molecular Endocrinology Research Center, Laval University Hospital Research Center (CRCHUL) and Laval University, Quebec, Canada. 1999 - 2009
  • Laboratory of Molecular Endocrinology, CHUL (Le Centre Hospitalier de l'Université Laval) Research Center, Québec, Canada. 1998 - 2008
  • Department of Medicine, Laval University Medical Research Center (CHUL), Québec, Canada. 1999

References

  1. Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women. Labrie, F., Cusan, L., Gomez, J.L., Côté, I., Bérubé, R., Bélanger, P., Martel, C., Labrie, C. Menopause (2009) [Pubmed]
  2. Comparable amounts of sex steroids are made outside the gonads in men and women: strong lesson for hormone therapy of prostate and breast cancer. Labrie, F., Cusan, L., Gomez, J.L., Martel, C., Bérubé, R., Bélanger, P., Bélanger, A., Vandenput, L., Mellström, D., Ohlsson, C. J. Steroid Biochem. Mol. Biol. (2009) [Pubmed]
  3. Changes in serum DHEA and eleven of its metabolites during 12-month percutaneous administration of DHEA. Labrie, F., Cusan, L., Gomez, J.L., Martel, C., Bérubé, R., Bélanger, P., Chaussade, V., Deloche, C., Leclaire, J. J. Steroid Biochem. Mol. Biol. (2008) [Pubmed]
  4. Effect of intravaginal DHEA on serum DHEA and eleven of its metabolites in postmenopausal women. Labrie, F., Cusan, L., Gomez, J.L., Côté, I., Bérubé, R., Bélanger, P., Martel, C., Labrie, C. J. Steroid Biochem. Mol. Biol. (2008) [Pubmed]
  5. Endocrinology and the prostate. Preface. Labrie, F. Best Pract. Res. Clin. Endocrinol. Metab. (2008) [Pubmed]
  6. Drug insight: breast cancer prevention and tissue-targeted hormone replacement therapy. Labrie, F. Nat. Clin. Pract. Endocrinol. Metab (2007) [Pubmed]
  7. Metabolism of DHEA in postmenopausal women following percutaneous administration. Labrie, F., Bélanger, A., Bélanger, P., Bérubé, R., Martel, C., Cusan, L., Gomez, J., Candas, B., Chaussade, V., Castiel, I., Deloche, C., Leclaire, J. J. Steroid Biochem. Mol. Biol. (2007) [Pubmed]
  8. Multiple intracrine hormonal targets in the prostate: opportunities and challenges. Labrie, F. BJU Int. (2007) [Pubmed]
  9. Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women. Labrie, F., Bélanger, A., Bélanger, P., Bérubé, R., Martel, C., Cusan, L., Gomez, J., Candas, B., Castiel, I., Chaussade, V., Deloche, C., Leclaire, J. J. Steroid Biochem. Mol. Biol. (2006) [Pubmed]
  10. Future perspectives of selective estrogen receptor modulators used alone and in combination with DHEA. Labrie, F. Endocr. Relat. Cancer (2006) [Pubmed]
  11. Dehydroepiandrosterone (DHEA) is an anabolic steroid like dihydrotestosterone (DHT), the most potent natural androgen, and tetrahydrogestrinone (THG). Labrie, F., Luu-The, V., Martel, C., Chernomoretz, A., Calvo, E., Morissette, J., Labrie, C. J. Steroid Biochem. Mol. Biol. (2006) [Pubmed]
  12. Dehydroepiandrosterone, androgens and the mammary gland. Labrie, F. Gynecol. Endocrinol. (2006) [Pubmed]
  13. Tetrahydrogestrinone induces a genomic signature typical of a potent anabolic steroid. Labrie, F., Luu-The, V., Calvo, E., Martel, C., Cloutier, J., Gauthier, S., Belleau, P., Morissette, J., Lévesque, M.H., Labrie, C. J. Endocrinol. (2005) [Pubmed]
  14. Gonadotropin-releasing hormone agonists in the treatment of prostate cancer. Labrie, F., Bélanger, A., Luu-The, V., Labrie, C., Simard, J., Cusan, L., Gomez, J., Candas, B. Endocr. Rev. (2005) [Pubmed]
  15. Is dehydroepiandrosterone a hormone?. Labrie, F., Luu-The, V., Bélanger, A., Lin, S.X., Simard, J., Pelletier, G., Labrie, C. J. Endocrinol. (2005) [Pubmed]
  16. Activity and safety of the antiestrogen EM-800, the orally active precursor of acolbifene, in tamoxifen-resistant breast cancer. Labrie, F., Champagne, P., Labrie, C., Roy, J., Laverdière, J., Provencher, L., Potvin, M., Drolet, Y., Pollak, M., Panasci, L., L'Espérance, B., Dufresne, J., Latreille, J., Robert, J., Samson, B., Jolivet, J., Yelle, L., Cusan, L., Diamond, P., Candas, B. J. Clin. Oncol. (2004) [Pubmed]
  17. Screening decreases prostate cancer mortality: 11-year follow-up of the 1988 Quebec prospective randomized controlled trial. Labrie, F., Candas, B., Cusan, L., Gomez, J.L., Bélanger, A., Brousseau, G., Chevrette, E., Lévesque, J. Prostate (2004) [Pubmed]
  18. Medical castration with LHRH agonists: 25 years later with major benefits achieved on survival in prostate cancer. Labrie, F. J. Androl. (2004) [Pubmed]
  19. Adrenal androgens and intracrinology. Labrie, F. Semin. Reprod. Med. (2004) [Pubmed]
  20. Major impact of hormonal therapy in localized prostate cancer--death can already be an exception. Labrie, F., Cusan, L., Gomez, J., Luu-The, V., Candas, B., Bélanger, A., Labrie, C. J. Steroid Biochem. Mol. Biol. (2004) [Pubmed]
  21. Current status of endocrine therapy in localized prostate cancer: cure has become a strong possibility. Labrie, F. Int. Braz. J. Urol (2004) [Pubmed]
  22. Extragonadal synthesis of sex steroids: intracrinology. Labrie, F. Ann. Endocrinol. (Paris) (2003) [Pubmed]
  23. The combination of a novel selective estrogen receptor modulator with an estrogen protects the mammary gland and uterus in a rodent model: the future of postmenopausal women's health?. Labrie, F., El-Alfy, M., Berger, L., Labrie, C., Martel, C., Bélanger, A., Candas, B., Pelletier, G. Endocrinology (2003) [Pubmed]
  24. Androgen blockade in prostate cancer in 2002: major benefits on survival in localized disease. Labrie, F. Mol. Cell. Endocrinol. (2002) [Pubmed]
  25. DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology. Labrie, F., Luu-The, V., Labrie, C., Simard, J. Front. Neuroendocrinol (2001) [Pubmed]
  26. EM-652 (SCH57068), a pure SERM having complete antiestrogenic activity in the mammary gland and endometrium. Labrie, F., Labrie, C., Bélanger, A., Simard, J., Giguère, V., Tremblay, A., Tremblay, G. J. Steroid Biochem. Mol. Biol. (2001) [Pubmed]
  27. Screening and early hormonal treatment of prostate cancer are accumulating strong evidence and support. Labrie, F. Prostate (2000) [Pubmed]
  28. Intracrinology: role of the family of 17 beta-hydroxysteroid dehydrogenases in human physiology and disease. Labrie, F., Luu-The, V., Lin, S.X., Simard, J., Labrie, C., El-Alfy, M., Pelletier, G., Bélanger, A. J. Mol. Endocrinol. (2000) [Pubmed]
  29. Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer. Candas, B., Cusan, L., Gomez, J.L., Diamond, P., Suburu, R.E., Lévesque, J., Brousseau, G., Bélanger, A., Labrie, F. Prostate (2000) [Pubmed]
  30. Role of 17 beta-hydroxysteroid dehydrogenases in sex steroid formation in peripheral intracrine tissues. Labrie, F., Luu-The, V., Lin, S.X., Simard, J., Labrie, C. Trends Endocrinol. Metab. (2000) [Pubmed]
  31. Intracrinology and the skin. Labrie, F., Luu-The, V., Labrie, C., Pelletier, G., El-Alfy, M. Horm. Res. (2000) [Pubmed]
  32. EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometrium. Labrie, F., Labrie, C., Bélanger, A., Simard, J., Gauthier, S., Luu-The, V., Mérand, Y., Giguere, V., Candas, B., Luo, S., Martel, C., Singh, S.M., Fournier, M., Coquet, A., Richard, V., Charbonneau, R., Charpenet, G., Tremblay, A., Tremblay, G., Cusan, L., Veilleux, R. J. Steroid Biochem. Mol. Biol. (1999) [Pubmed]
  33. Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trial. Labrie, F., Candas, B., Dupont, A., Cusan, L., Gomez, J.L., Suburu, R.E., Diamond, P., Lévesque, J., Belanger, A. Prostate (1999) [Pubmed]
  34. DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging. Labrie, F., Bélanger, A., Luu-The, V., Labrie, C., Simard, J., Cusan, L., Gomez, J.L., Candas, B. Steroids (1998) [Pubmed]
 
WikiGenes - Universities